Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$210.01B | 158.4x | 0.88 | NT$632 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.7% Upside | Upgrade to Pro+ | |
Bora Pharmas | Taiwan | Healthcare | Pharmaceuticals | NT$76.27B | 23.8x | 1.76 | NT$757 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.6% Upside | Upgrade to Pro+ | |
Lotus Pharma | Taiwan | Healthcare | Pharmaceuticals | NT$71.56B | 17.4x | -1.18 | NT$270 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.6% Upside | Upgrade to Pro+ | |
Oneness Biotech | TPEX | Healthcare | Pharmaceuticals | NT$67.51B | -68.5x | NT$141.50 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$53.03B | -169.1x | 1.28 | NT$321.50 | 9.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -14.5% Downside | Upgrade to Pro+ | |
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$40.86B | -20.6x | 0.3 | NT$54.80 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Center Laboratories | TPEX | Healthcare | Pharmaceuticals | NT$34.96B | -19.2x | 0.37 | NT$49 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pegavision | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$34.01B | 16.6x | 1.19 | NT$436 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.1% Upside | Upgrade to Pro+ | |
EirGenix | TPEX | Healthcare | Pharmaceuticals | NT$26.82B | -31.2x | 0.55 | NT$87.60 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.5% Upside | Upgrade to Pro+ | |
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$21.87B | -188.7x | -4.23 | NT$80.10 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Universal Vision BioTech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$21.82B | 19.2x | 1.51 | NT$257.50 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4% Upside | Upgrade to Pro+ | |
SPT | Taiwan | Healthcare | Pharmaceuticals | NT$20.12B | 49.5x | 0.96 | NT$25.45 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3% Upside | Upgrade to Pro+ | |
TTY Biopharm | TPEX | Healthcare | Pharmaceuticals | NT$18.40B | 16.2x | -24.61 | NT$74 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.3% Upside | Upgrade to Pro+ | |
Y.S.H. | Taiwan | Healthcare | Pharmaceuticals | NT$16.70B | 15.5x | 0.33 | NT$62.70 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$16.69B | -7.8x | 0.06 | NT$72.80 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Easywell Biomedical | TPEX | Healthcare | Pharmaceuticals | NT$16.21B | -109.9x | -25.8 | NT$120 | -9.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Synmosa Biopharma | TPEX | Healthcare | Pharmaceuticals | NT$15.84B | 22.8x | 1.67 | NT$37.30 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.6% Downside | Upgrade to Pro+ | |
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.92B | -121.6x | -2.46 | NT$117 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen Vaccine Biologics | TPEX | Healthcare | Pharmaceuticals | NT$14.91B | -21.3x | -0.38 | NT$45.35 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taidoc Tech | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$14.83B | 13.2x | -0.36 | NT$155.50 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.5% Downside | Upgrade to Pro+ | |
Excelsior | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$14.41B | 18.5x | 3.09 | NT$88.20 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.7% Downside | Upgrade to Pro+ | |
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.27B | 20.1x | 0.61 | NT$262 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$12.61B | 34.6x | 1.71 | NT$87.80 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.4% Upside | Upgrade to Pro+ | |
CHO Pharma | TPEX | Healthcare | Pharmaceuticals | NT$12.22B | -46x | -1.58 | NT$57.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Formosa Lab | Taiwan | Healthcare | Pharmaceuticals | NT$11.99B | 47.5x | -0.65 | NT$99.70 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.5% Upside | Upgrade to Pro+ | |
SCPC | Taiwan | Healthcare | Pharmaceuticals | NT$11.53B | 13.5x | -16.06 | NT$64.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24% Upside | Upgrade to Pro+ | |
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$11.40B | -5.3x | -0.28 | NT$69.50 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ADIM | Taiwan | Healthcare | Pharmaceuticals | NT$11.36B | -18.7x | 0 | NT$27.20 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$11.27B | -13x | -1.27 | NT$82.40 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SCI Pharmtech | Taiwan | Healthcare | Pharmaceuticals | NT$10.73B | 74.6x | -1.15 | NT$89.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |